![Gail Schulze](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gail Schulze
Direttore/Membro del Consiglio presso CERUS CORPORATION
Patrimonio netto: 287 619 $ in data 30/06/2024
Profilo
Ms. Gail G.
Schulze is an Independent Director at Cerus Corp.
She is on the Board of Directors at Cerus Corp.
Ms. Schulze was previously employed as a Chairman by Zosano Pharma, Inc., a Chief Executive Officer & Director by YM Biosciences USA, Inc., a President by YM BioSciences, Inc., a COO & Deputy Chief Executive Officer by Aventis Behring, a Vice President by Allegiance Healthcare Corp., a President-Renal Division Europe by Baxter Healthcare Corp., and a President, Chief Executive Officer & Director by Eximias Pharmaceutical Corp.
She received her undergraduate degree from the University of California, Santa Cruz and an MBA from Stanford Graduate School of Business.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
CERUS CORPORATION
0.09% | 05/06/2024 | 163 420 ( 0.09% ) | 287 619 $ | 30/06/2024 |
Posizioni attive di Gail Schulze
Società | Posizione | Inizio |
---|---|---|
CERUS CORPORATION | Direttore/Membro del Consiglio | 25/10/2007 |
Precedenti posizioni note di Gail Schulze
Società | Posizione | Fine |
---|---|---|
ZP Opco, Inc.
![]() ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Presidente | 01/06/2012 |
YM Biosciences USA, Inc.
![]() YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | Amministratore Delegato | 01/03/2007 |
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Presidente | 01/03/2007 |
Aventis Behring | Direttore operativo | 01/01/2004 |
Allegiance Healthcare Corp.
![]() Allegiance Healthcare Corp. Medical DistributorsDistribution Services Allegiance Healthcare Corp. manufactures and distributes pharmaceutical products. It offers medical, surgical, and laboratory products. The company provides services to hospitals, laboratories, and others in the health care industries. The company was founded in 1999 and is headquartered in Waukegan, IL. | Corporate Officer/Principal | 01/01/1997 |
Formazione di Gail Schulze
University of California, Santa Cruz | Undergraduate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CERUS CORPORATION | Health Technology |
Aziende private | 7 |
---|---|
Aventis Behring | Health Technology |
Allegiance Healthcare Corp.
![]() Allegiance Healthcare Corp. Medical DistributorsDistribution Services Allegiance Healthcare Corp. manufactures and distributes pharmaceutical products. It offers medical, surgical, and laboratory products. The company provides services to hospitals, laboratories, and others in the health care industries. The company was founded in 1999 and is headquartered in Waukegan, IL. | Distribution Services |
Baxter Healthcare Corp.
![]() Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
ZP Opco, Inc.
![]() ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Health Technology |
Eximias Pharmaceutical Corp.
![]() Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Health Technology |
YM Biosciences USA, Inc.
![]() YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | Health Technology |
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Gail Schulze